S2 Episode 5: Posttransplant Monitoring in Myelofibrosis

Join Drs Tania Jain and Rachel Salit as they explore evolving definitions of remission, relapse monitoring, and patient-centered transplant decisions in myelofibrosis care.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002057. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Primary Myelofibrosis https://emedicine.medscape.com/article/197954-overview

Role of Hematopoietic Stem Cell Transplantation in Patients With Myeloproliferative Disease https://pubmed.ncbi.nlm.nih.gov/25459177/

Decreasing Chronic Graft-Versus-Host Disease Rates in All Populations https://pubmed.ncbi.nlm.nih.gov/39167805/

Diagnosis and Evaluation of Prognosis of Myelofibrosis: A British Society for Haematology Guideline https://pubmed.ncbi.nlm.nih.gov/37932932/

Prognostic Value of Blasts in Peripheral Blood in Myelofibrosis in the Ruxolitinib Era https://pubmed.ncbi.nlm.nih.gov/32697338/

Acute Myeloid Leukemia (AML) https://emedicine.medscape.com/article/197802-overview

CIBMTR Myelofibrosis Medicare Study https://cibmtr.org/CIBMTR/Studies/Research-Programs/Clinical-Trials-Support/Medicare-Clinical-Trials#CMSMF

Proposals for Revised International Working Group-European LeukemiaNet Criteria for Anemia Response in Myelofibrosis https://pubmed.ncbi.nlm.nih.gov/39116296/

Utility of Assessing CD3+ Cell Chimerism Within the First Months After Allogeneic Hematopoietic Stem-Cell Transplantation for Acute Myeloid Leukemia https://pubmed.ncbi.nlm.nih.gov/35064642/

Clearance of Driver Mutations After Transplantation for Myelofibrosis https://pubmed.ncbi.nlm.nih.gov/39778169/

Donor Lymphocyte Infusion and Molecular Monitoring for Relapsed Myelofibrosis After Hematopoietic Cell Transplantation https://pubmed.ncbi.nlm.nih.gov/37404772/